---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-22-000029"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2022-05-09T23:59:59+00:00"
generated_at: "2026-06-25T22:46:08.212214+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q1 revenue $543M, GAAP net loss $38.1M, adjusted EPS $1.82

## Summary
- Revenue $543.1M, up 71% from $318.0M in Q1 2021.
- GAAP net loss of $38.1M ($1.61 per diluted share) vs net income of $23.7M ($1.09) in Q1 2021.
- Adjusted diluted EPS $1.82, up from $1.62; adjusted EBITDA $84.9M vs $57.8M.
- GAAP gross margin declined to 31% from 35% in Q1 2021.

## SEC filing metadata
- accession: 0000883984-22-000029
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2022-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398422000029/0000883984-22-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398422000029/icui-20220509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-22-000029
- JSON: https://secwatch.observer/filing/0000883984-22-000029.json
- Plain text: https://secwatch.observer/filing/0000883984-22-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.